SBMSK and Dendrite Clinical Systems to establish National Registry of Bariatric and Metabolic Surgery of Kazakhstan
The Society of Bariatric and Metabolic Surgeons of Kazakhstan (SBMSK) and Dendrite Clinical Systems will establish a National Registry of Bariatric and Metabolic Surgery of Kazakhstan. The purpose of the Registry is to collect information on patients and bariatric procedures in the country so researchers can use the data to improve outcomes in patients.
“Bariatric surgery in Kazakhstan is a relatively new branch of medicine. Therefore, I really wanted this part of the surgery to go the right way from the very beginning. We wanted to understand and see the overall picture of bariatric surgery in our country. What procedures are performed and in what quantity? what quality and result?,” explained President of SBMSK, Professor Oral Ospanov, Professor of Medicine and Surgery, Head of Department of Laparoscopic & Bariatric Surgery at Astana Medical University, in the Republic of Kazakhstan. “And in order to have an objective picture of what is happening, we created a bariatric register, looking at the experience of other countries. It was important to understand where we stand and to determine the population's need for bariatric surgery.”
The registry uses Dendrite’s intuitive Intellect-Web registry software that facilitates the collection, recording and analysis of patient and procedural data from all bariatric procedures performed at the hospital including baseline demographic data, procedure type (including OAGB/MGB), all complications that might occur and also notes the severity of post-op complications (using the Clavien-Dindo classification). The system also takes into account the use of gastric balloons so that a subsequent first surgical procedure becomes a Primary Procedure and does not appear as a revision.
"The benefits we can get from launching the register are enormous. The quality and safety of various types of operations will be assessed. The data will be used for analysis and research, as well as improving the quality of care provided,” Professor Ospanov added. “The data we receive will be reported to the Ministry of Health and the Health Insurance Fund to make appropriate decisions. Ultimately to show the medical community and the public that this is a very safe surgery that can treat many diseases, as well as overcome the stigma regarding the treatment of obesity and related diseases, which could have formed in our country.”
About Dendrite
Dendrite Clinical Systems is a UK-headquartered international company with over a 30-year track record as a specialist provider of secure clinical registries, analysis software and consultancy services for the international healthcare sector, specifically for clinical research, multi-centre real-world studies, observational registries, international, national and hospital clinical databases.
Dendrite has been recognised as a leading provider of clinical registries across various specialties with a unique track record of implementing over 200 major clinical registry systems globally including systems for major research projects for medical device companies, CROs and pharmaceutical companies.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


